Scrolling Banners
RSS Icon Industry News RSS Feed
Welcome to Horse Health Magazine
The UK's leading Equine Health and Well-being magazine for the professional. 
Every issue of the magazine is mailed directly to those whose profession makes them responsible for the health, well-being and treatment of horses every day. Horse Health's core readership is made up of the industry's decision-makers - the people with significant buying power at riding schools, livery yards, training schools, bloodstock agencies, veterinary practices, breeders and competition yards.

Read Online - Click here
Top News Story From Horse Health Magazine
The perfect ratio for the perfect joint supplement May 2017 | The perfect ratio for the perfect joint supplement
When I first heard of this new equine joint supplement, I'll admit I was a little apprehensive at the claims being made. Never have I heard of a supplement that starts to work within just a few days. Yet speaking to Co-Founder Ryan, who had the passion and knowledge that you can't help but admire, I soon became rather intrigued and excited to try my 14 year old exracehorse on this new product. The next day, a 1kg tub of white magic turns up which I started to feed immediately.  
Feeding a joint supplement was through choice, rather than through the management of arthritis/other physiological issues. I want to do all I can to ensure that my horse feels as good as he possibly can, so I can get the very best out of him. Having endured a very active racing life, I feel he would appreciate all the help he can get, hence my excitement to try the product that is 'the highest specification joint supplement on the market' with a 10-10-4 ratio of Glucosamine HCl, MSM & Chondroitin, a ratio that has been proven to be the most beneficial for the horse, where only the highest grade active ingredients are used. The brains behind BETTALife have clearly done a lot of research into what works and what is a pointless additive (of which, none are used in their product), after years of working in Nutriton. 
Ollie took to the supplement very well (not a lot would stop him eating his hard feed!) - I went straight in with maintenance level (two thirds of a 15g scoop once a day) as he was already on a joint supplement, having been on one since I got him last October. The first thing I noticed was his enthusiasm for hill work! Living in the middle of The Cotswold hills I am fortunate enough to be able to incorporate this into his workouts. As we increase his workload as we move towards the Summer season and our first RoR camp at Bicton Arena, I have been impressed with how he's feeling. He is showing good stretch and is able to really engage his backend when I ask. His stride seems bigger and more even and he seems capable of smaller circles when schooling on the flat. 
Finally, what really impressed me was his flexion after a recent visit from the farrier - previously he would look a little stiff in the hock of the nearhind when his back foot was being treated and want to snatch it away. After 1 month on Pharmaquin HA, he was completely different - he lifted and held his hind leg perfectly (and who doesn't want a happy farrier!?)  
I'm totally thrilled with this product - all I want is for my boy to be happy and able to work to the best of his ability in a comfortable manner, something that is most certainly happening now. I'm really looking forward to the Summer ahead and wouldn't dream of putting Ollie on anything else. Now to get the first event entered…  
Get yours now at for '64.99 (1000g) - it really is worth every penny.  
Telephone 01937 580782
More News From Horse Health Magazine
Article References

Pathophysiology and Nutritional Management of Pituitary Pars Intermedia Dysfunction – Cushing’s Syndrome
By Catherine Hale, Product and Nutrition Manager for Allen & Page and Company Nutritionist Claire Lawrence

Carson NR. (2003) Physiology of Behaviour, Pearson Education
DeMaria JE, Lerant AA and Freeman ME. (1999) Prolactin activates all three populations of hypothalamic neuroendocrine dopaminergic neurons in ovariectomized rats. Brain Res. 837 pp.236-241.
Geor R (2010). Digestive strategy and flexibility in horses with reference to dietary carbohydrates. In: the impact of nutrition on health and welfare of horses, EAAP 128.
Grenager N (2010) How does Cushing’s Disease relate to laminitis? Advances in diagnosis and treatment. J Eq Vet Sci, 30 (9) pp.482-490.
Glover CM, Miller LM, Dybdal NO, Lopez A, Duckett WM and McFarlane D (2009) Extrapituitary and pituitary pathological findings in horses with pituitary pars intermedia dysfunction: A retrospective study. 29 (3) pp.146-153.
Lee Z-Y, Zylstra R and Haritou SJA (2010) The use of adrenocorticotrophic hormone as a potential biomarker of pituitary pars intermedia dysfunction in horses. The Vet J, 185 pp.58-61.
McFarlane D., Cribb AE. (2005) Systemic and pituitary pars intermedia antioxidant capacity associated with pars intermedia oxidative stress and dysfunction in horses. Am J Vet Res, 66 pp.2065-2072.
McFarlane D., Donaldson MT, Saleh TM and Cribb AE. (2003) The role of dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction (equine Cushing’s disease). In: Proceedings of the 49th Annual Convention of the American Association of Equine Practitioners, New Orleans, USA. pp.233-237.
Orth DN and Nicholson WE. (1982) Bioactive and immunoactive adrenocorticotrophin in normal equine pituitary and pituitary tumors of horse’s with Cushing’s disease. Endocrinology, 111 pp.559-563.
Schott HC. (2002) Pituitary pars intermedia dysfunction: equine Cushing’s disease. Vet Clin North Am, 18 pp.237-270.
Saland LC. (2001) The mammalian pituitary intermediate lobe: an update on innervations and regulation. Brain Res Bull, 54 pp.587-593.
Treiber KH, Kronfeld DS, Hess TM, Byrd BM, Splan RK and Staniar WB. (2006). Evaluation of genetic and metabolic predispositions and nutritional risk factors for pasture-associated laminitis in ponies. J Am Vet Med Assoc, 228. pp.1538-1545.
Wilson MG, Nicholson WE, Holscher MA, Sherrell BJ, Mount CD and Orth DN. (1982) Pro-opiolipomelanocortin peptides in normal pituitary, pituitary tumor and plasma of normal and Cushing’s horses. Endocrinology, 110. pp.941-954.